AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study Meeting Abstract
| Authors: | Dummer, R.; Robert, C.; Chapman, P. B.; Sosman, J. A.; Middleton, M.; Bastholt, L.; Kemsley, K.; Cantarini, M. V.; Morris, C.; Kirkwood, J. M. |
| Abstract Title: | AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study |
| Meeting Title: | 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 26 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2008 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2008-05-20 |
| Start Page: | 491s |
| Language: | English |
| ACCESSION: | WOS:000208457403209 |
| DOI: | 10.1200/jco.2008.26.15_suppl.9033 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9033 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
